English 
Spanish 
3 min read
0 comments
Pharmaceutical multinational ACG invests R$100 million in expanding its factory in Pouso Alegre, increasing capsule production capacity by 60%.
The pharmaceutical multinational ACG announced on Wednesday (25) the reopening of its factory specializing in the production of capsules, located in Pouso Alegre, in the South of Minas Gerais. The project had an investment of over R$ 100 million, which aims to increase the unit's production capacity by 60%. With this expansion, ACG expects to reach the mark of 20 billion capsules produced annually.
New job opportunities at ACGA
With the expansion of factory, ACG created 80 new jobs in the region. The unit currently has around 300 direct employees and 100 service providers.
New hires include opportunities for positions such as print operator and production manager.
- Akaer closes million-dollar contract to produce components for the C-390 and Praetor 600: participation in planes that have already conquered more than 10 countries!
- Hamad Port, a monumental work that revolutionized Logistics, Engineering and Maritime Trade in the Middle East
- After Brazilian uranium: China invests US$1 billion in Bolivian LITHIUM and advances on 24,6% of world reserves
- Argentina negotiating $2,3 billion project for three Riachuelo Class submarines based on Brazilian model
The company is also looking for professionals to replace staff.
Global presence and certifications
Founded in 1964, ACG is a multinational company that operates in more than 100 countries and has more than 4,5 employees around the world.
A factory de Pouso Alegre is responsible for the production of capsules intended for the pharmaceutical and nutraceutical markets, holding important certifications such as GMP, Halal and Kosher.
These certifications guarantee the quality and safety of the products manufactured. ACG, as a pharmaceutical multinational, always seeks excellence in its processes.
Market growth and expansion
According to Raphael Sideris, ACG's sales and marketing director for Brazil and Latin America, the expansion of factory will allow the multinational to serve the entire Brazilian market and a significant part of capsule consumption in Latin America.
He explains that the Latin American market consumes approximately 40 billion capsules, and Brazil alone accounts for around 20 billion.
With the new capacity, ACG will be able to fully meet domestic demand.
In addition to increasing production, the factory expansion will also enable ACG to enter the inhalation capsules market.
With its unit in Pouso Alegre, opened in 2019, ACG is already a leader in the supply of capsules for the domestic market and is positioning itself to assume leadership in Latin America.
Local and regional impact of ACG
The expansion of factory ACG in Pouso Alegre not only strengthens the presence of the pharmaceutical multinational in Brazil, but also generates a positive impact on the local economy.
By creating 80 new jobs, ACG contributes to reducing unemployment in the region and offers opportunities for professional development for residents.
In addition, ACG invests in partnerships with local suppliers, stimulating trade and industry in the region, thus benefiting the community surrounding the factory.
ACG stands out in the pharmaceutical sector not only for its size, but also for its dedication to innovation.
With an investment of R$100 million, the pharmaceutical multinational is focused on developing new products that meet the needs of the capsule market.
The company is investing in research and development to create capsules with advanced formulations and innovative technologies.
This commitment to innovation not only improves product quality, but also positions ACG as a reference in the pharmaceutical sector, ready to meet growing consumer demand.
Be the first to react!